Informazione:
Errore:
ID
14568
Descrizione
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02144675
collegamento
https://clinicaltrials.gov/show/NCT02144675
Keywords
versioni (1)
- 21/04/16 21/04/16 -
Caricato su
21 aprile 2016
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT02144675
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT02144675
- StudyEvent: Eligibility
Similar models
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT02144675
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
aml
Item
patients must have a diagnosis of non-m3 aml (patients with m3 subtype are excluded); determination of the presence of cytogenetic abnormalities will be by standard cytogenetics +/- fluorescent-in-situ (fish) studies; additional molecular analyses for nucleophosmin (npm) mutation and fms-related tyrosine kinase 3 (flt3) internal tandem duplication will be obtained as a part of standard care by institutional procedures
boolean
C0023467 (UMLS CUI [1])
leukemic blast count
Item
leukemic blast count > 1500/mm^3 of peripheral blood
boolean
C2697913 (UMLS CUI [1])
eastern cooperative oncology group (ecog) performance status
Item
patients must have an eastern cooperative oncology group (ecog) performance status =< 3
boolean
C1520224 (UMLS CUI [1])
total bilirubin
Item
total bilirubin < 2 times the institutional upper limit of normal (uln)
boolean
C0201913 (UMLS CUI [1])
aspartate aminotransferase
Item
aspartate aminotransferase (ast) (serum glutamic oxaloacetic transaminase [sgot]) < 3 times the institutional uln
boolean
C0201899 (UMLS CUI [1])
serum creatinine
Item
serum creatinine < 1.5 times the institutional uln
boolean
C0201976 (UMLS CUI [1])
Left ventricular ejection fraction
Item
multi gated acquisition scan (muga) or echocardiogram with left ventricular ejection fraction (lvef) > 50%
boolean
C0428772 (UMLS CUI [1])
negative pregnancy test
Item
women of childbearing potential must have a negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
psychiatric illness
Item
no uncontrolled psychiatric illness that the principal investigator feels will compromise obtaining informed consent from a patient
boolean
C0004936 (UMLS CUI [1])
informed consent
Item
patient must be informed of the investigational nature of this study and must give written informed consent in accordance with institutional and federal guidelines; patients who do not provide informed consent will not be eligible for the study
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
any coexisting medical condition or medications precluding full compliance with any of the arms of the study
boolean
C0525058 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,2])
allergies to any investigational drugs
Item
allergies to any investigational drugs and/or to the chemotherapeutic agents
boolean
C0020517 (UMLS CUI [1,1])
C0729502 (UMLS CUI [1,2])
C0729502 (UMLS CUI [1,2])
allergies to any non-steroidal anti-inflammatory drugs
Item
allergies to any non-steroidal anti-inflammatory drugs (nsaids)/salicylates (e.g., aspirin)
boolean
C0020517 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C0003211 (UMLS CUI [1,2])
gastrointestinal hemorrhage
Item
endoscopically documented upper or lower gastrointestinal (gi) related hemorrhage within last 6 months; also, patients with a clinical diagnosis of gi bleeding requiring blood transfusions will be excluded
boolean
C0017181 (UMLS CUI [1])